“…In fact, synthesis of several compounds possessing melatonin antagonist or agonist activity was already reported [Flaugh et al, 1979;Vakkuri et al, 1984;Laudon et al, 1987;Dubocovich, 19871. The biological effects of these analogues were tested under different experimental paradigms [Richardson et al, 1983;Vaughan et al, 1986;Dubocovich, 1987;Weaver et al, 19881, leading, in some cases, to controversial results in different species [ Laudon et al, 1987;Zizapel and Laudon, 1987;Lincoln and Kelly, 1989;Pevet et al, 19891. Some of the putative analogues were also tested for their capacity to displace labelled melatonin from its receptor and were found differing to a great extent in their potency in diverse species [Dubocovich and Takahashi, 1987;Duncan et al, 1988;Stankov et al, 1989 Prazosin, a selective alpha-1 adrenoceptor antagonist was reported to be a potent displacer of the high-affinity component of 2-[ 125I]iodomelatonin binding in hamster brain [Niles et al, 19871 but possessed low or no potency in a transplantable neoplasm [Stankov et at., 19891, rabbit, horse, and sheep brain membranes [Stankov et al, 1990b1, rat median eminence membranes [Stankov, unpublished] and rat suprachiasmatic nuclei [ Laitinen and Saavedra, 19901. Therefore, we report here results obtained under in vivo and in vitro experimental conditions aimed at determining whether the biological effects of melatonin can be duplicated or antagonized by prazosin.…”